Enzo Biochem (ENZ) Announces Favorable Judgment by U.S. Patent Office in an Interference against Bayer HealthCare for a Universal Diagnostic Detection System. The effect of this judgment is that Enzo will receive a full seventeen year patent for all the inventions covered by its claims, which term will commence on the date of issuance of the patent. – Business Wire
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!